Zydus Lifesciences appoints Shelina Parikh as Additional Director, Independent Director
Advertisement
Ahmedabad: Zydus Lifesciences has approved the appointment of Shelina Parikh as an Additional Director as well as Independent Director of the Company for the first term of 5 (five) consecutive years.
Shelina Parikh is the Joint Managing Director of TechNova Group, a privately held, family business group with interests in imaging solutions, chemicals and industrial products. Its main company, TechNova Imaging Systems, is the largest manufacturer of offset and digital print solutions in India, and the fifth largest in the world. TechNova’s business portfolio covers Specialty Chemicals, Offset Printing Plates, Digital Print Media and Digital Print Equipment & Software. Globally recognised as a pioneer, TechNova’s innovative products cater to a range of industries such as Commercial & Newspaper Printing, Packaging, Publishing, Signage, Photo, Textile and Medical Imaging.
As Joint MD, she is passionate about innovation, technology and mentoring leaders. She is instrumental in strengthening TechNova’s strategic operations, business transformation, market leadership position, digitisation and new growth engines. Her emphasis on the spiritual values of zero-ego, humility, trust, transparency, kindness and life-time employment are combined with a focus on high performance metrics, passion for excellence, leaner structures and strong corporate governance. This unique ethos has established a vibrant, innovative organisation that is recognised as a global leader in the Imaging Industry. She is a member of Young Presidents Organisation and a founding member of Entrepreneurs Organisation in India.
She completed her B.A. from Brown University and MBA from Harvard Business School. She remains engaged with Harvard Business School, as Vice President of the HBS Global Alumni Board and member of the HBS South Asia Advisory Board.
Headquartered in Ahmedabad, Zydus Lifesciences Limited is an innovative, global lifesciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group has a significant presence in cancer-related therapies and offers a wide range of solutions with cytotoxic, supportive & targeted drugs.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.